Spinraza (Nusinersen)

Spinraza is ann intrathecally administered antisense oligonucleotide (ASO) for treatment of spinal muscular atrophy (SMA). SMA is caused by deletions or mutations in the survival motor neuron 1 (SMN1) gene; these gene alterations lead to a deficiency of survival motor...